Stock listing
OTC:HLMAF Halma plc Stock
US listing (OTC) of Halma plc · home listing LSE:HLMA
Follow Halma plc into a list and get an email when it puts out news.
Share price · OTC:HLMAF
$42.00 USD -4.03 (-8.8%)
Close on Nov 20, 2026
- Day range
- $42.00 – $42.00 USDNov 20, 2026
- Volume
- 200 sharesNov 20, 2026
- Market cap
- $15.86B USDAt the close on Nov 20, 2026 · price × 377.7M shares outstanding
- 52-week range
- $41.62 – $66.22 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $377,366 USDMedian day 3,400 shares · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| LSE:HLMA · Home | 3,256.00p GBX (pence) | -150.00 (-4.4%) | 1,076,541 | 3,428.00p | 3,440.03p | 3,256.00p | 3,406.00p | Close on Nov 20, 2026 |
| OTC:HALMY | $83.88 USD | -6.77 (-7.5%) | 9,339 | $87.58 | $87.58 | $83.88 | $90.65 | Close on Nov 20, 2026 |
| OTC:HLMAF | $42.00 USD | -4.029 (-8.8%) | 200 | $42.00 | $42.00 | $42.00 | $46.03 | Close on Nov 20, 2026 |
| Frankfurt:H11 | €41.74 EUR | +0.74 (+1.8%) | — | €41.74 | €41.74 | €41.74 | €41.00 | Close on Nov 20, 2026 |
| Dusseldorf:H11 | €38.88 EUR | -2.66 (-6.4%) | — | €41.20 | €41.20 | €38.88 | €41.54 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · OTC:HLMAF · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $44.69 | +0.537 | +1.2% | $44.67 | $45.25 | $43.83 | 4,700 | |
| $44.15 | -1.961 | -4.3% | $45.31 | $45.44 | $43.98 | 2,600 | |
| $46.11 | -1.596 | -3.3% | $45.86 | $47.07 | $45.86 | 8,800 | |
| $47.71 | +0.09 | +0.2% | $46.43 | $47.71 | $46.34 | 6,100 | |
| $47.62 | +2.909 | +6.5% | $47.29 | $48.07 | $46.23 | 6,500 | |
| $44.71 | -0.561 | -1.2% | $44.63 | $46.37 | $44.63 | 3,200 | |
| $45.27 | -0.144 | -0.3% | $44.86 | $46.82 | $44.86 | 2,800 | |
| $45.42 | +0.348 | +0.8% | $44.26 | $46.24 | $44.25 | 3,400 | |
| $45.07 | +0.144 | +0.3% | $44.75 | $45.07 | $43.03 | 8,238 | |
| $44.92 | +1.422 | +3.3% | $44.09 | $45.38 | $42.56 | 19,255 | |
| $43.50 | -1.245 | -2.8% | $43.13 | $43.50 | $41.62 | 4,600 | |
| $44.75 | -0.812 | -1.8% | $44.48 | $44.75 | $43.71 | 6,000 | |
| $45.56 | +0.637 | +1.4% | $43.96 | $45.62 | $43.96 | 1,700 | |
| $44.92 | +0.787 | +1.8% | $43.68 | $44.98 | $43.68 | 3,300 | |
| $44.14 | -1.515 | -3.3% | $44.05 | $45.58 | $43.13 | 4,000 | |
| $45.65 | +0.301 | +0.7% | $44.33 | $45.65 | $44.19 | 1,600 | |
| $45.35 | -0.682 | -1.5% | $43.71 | $45.35 | $43.71 | 11,200 | |
| $46.03 | -0.372 | -0.8% | $45.34 | $46.34 | $44.78 | 3,000 | |
| $46.40 | +1.048 | +2.3% | $45.02 | $46.56 | $44.43 | 3,713 | |
| $45.36 | +0.185 | +0.4% | $45.57 | $47.20 | $45.36 | 4,439 | |
| $45.17 | -1.489 | -3.2% | $44.65 | $46.98 | $44.31 | 10,500 | |
| $46.66 | +1.089 | +2.4% | $44.31 | $46.66 | $44.26 | 5,700 | |
| $45.57 | -0.216 | -0.5% | $43.63 | $46.39 | $43.63 | 4,500 | |
| $45.79 | -0.992 | -2.1% | $45.60 | $47.57 | $45.60 | 3,258 | |
| $46.78 | +0.241 | +0.5% | $45.11 | $47.00 | $45.11 | 3,672 | |
| $46.54 | +1.694 | +3.8% | $46.61 | $49.75 | $45.31 | 3,100 | |
| $44.84 | -0.687 | -1.5% | $45.30 | $47.13 | $44.33 | 3,400 | |
| $45.53 | -0.505 | -1.1% | $45.62 | $47.47 | $44.42 | 2,400 | |
| $46.04 | +1.076 | +2.4% | $45.53 | $46.04 | $44.84 | 2,932 | |
| $44.96 | -0.09 | -0.2% | $45.18 | $47.08 | $44.96 | 2,836 | |
| $45.05 | -0.323 | -0.7% | $45.37 | $46.74 | $45.05 | 3,400 | |
| $45.37 | -0.619 | -1.3% | $44.75 | $47.10 | $44.75 | 3,700 | |
| $45.99 | -1.654 | -3.5% | $47.08 | $47.08 | $44.86 | 2,900 | |
| $47.65 | -0.709 | -1.5% | $46.86 | $48.37 | $46.69 | 2,702 | |
| $48.35 | +1.121 | +2.4% | $46.84 | $48.35 | $45.33 | 8,511 | |
| $47.23 | +0.065 | +0.1% | $45.83 | $47.23 | $45.76 | 2,300 | |
| $47.17 | +0.661 | +1.4% | $47.68 | $47.68 | $46.05 | 2,100 | |
| $46.51 | -0.294 | -0.6% | $45.26 | $46.84 | $44.30 | 3,900 | |
| $46.80 | -0.508 | -1.1% | $45.28 | $47.72 | $45.15 | 10,303 | |
| $47.31 | -0.483 | -1.0% | $47.03 | $47.87 | $46.32 | 2,580 | |
| $47.79 | +0.052 | +0.1% | $49.35 | $49.35 | $47.79 | 12,100 | |
| $47.74 | -1.036 | -2.1% | $47.74 | $49.06 | $47.74 | 6,600 | |
| $48.78 | -1.844 | -3.6% | $48.48 | $49.74 | $48.47 | 2,300 | |
| $50.62 | +1.615 | +3.3% | $51.04 | $51.09 | $48.57 | 132,600 | |
| $49.00 | -0.135 | -0.3% | $46.46 | $49.70 | $46.46 | 2,900 | |
| $49.14 | +0.941 | +2.0% | $48.65 | $49.18 | $47.13 | 2,300 | |
| $48.20 | +0.294 | +0.6% | $47.16 | $48.38 | $46.69 | 2,794 | |
| $47.91 | -1.49 | -3.0% | $47.43 | $47.94 | $47.43 | 1,789 | |
| $49.40 | +0.022 | 0.0% | $49.10 | $49.53 | $48.48 | 5,242 | |
| $49.37 | -0.651 | -1.3% | $48.27 | $49.70 | $48.05 | 2,700 | |
| $50.02 | +0.539 | +1.1% | $50.75 | $50.75 | $48.52 | 5,400 | |
| $49.49 | +0.322 | +0.7% | $50.94 | $50.94 | $46.86 | 3,300 | |
| $49.16 | +1.457 | +3.1% | $47.93 | $49.16 | $46.86 | 55,800 | |
| $47.71 | -0.974 | -2.0% | $47.64 | $48.84 | $47.64 | 5,800 | |
| $48.68 | +1.88 | +4.0% | $48.41 | $48.68 | $47.64 | 2,700 | |
| $46.80 | -0.225 | -0.5% | $47.80 | $47.80 | $46.80 | 1,800 |
- Ticker
- OTC:HLMAF
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 19, 2026
Half Year Results 2026/27 (Announcement)
Latest earnings call · Nov 19, 2026
Halma (LSE:HLMA) Q2 2027 Earnings Call
Replay and transcript
Latest deck · Nov 19, 2026
H1 2026/27 Earnings Presentation
Earnings · 40 slides
Latest news
Director/PDMR Shareholding
Oct 1, 2026
Closed $44.84 (-1.5%) on Oct 1, 2026
Halma strengthens healthcare capabilities to support safer, more efficient diagnostics
Jul 7, 2026
Closed $49.11 (-3.5%) on Jul 7, 2026
Halma strengthens its position in specialist healthcare markets with bolt-on acquisitions
Jul 2, 2026
Closed $53.13 (+1.1%) on Jul 2, 2026
TR1 Notification of Major Holdings
Jun 24, 2026
Closed $51.18 (-0.9%) on Jun 24, 2026
Directorate change
Jun 12, 2026
Closed $52.72 (-3.6%) on Jun 12, 2026
Full Year Results 2025/26 (Announcement)
Jun 11, 2026
Closed $54.68 (-12.2%) on Jun 11, 2026
Appointment of Sector Chief Executives
May 28, 2026
Closed $63.13 (+0.2%) on May 28, 2026
Halma plc on 6ix
- News releases
- 14 in the last 12 months · 133 in all · newest Nov 19, 2026 · oldest 1999
- Calls
- 9 calls with a replay · 9 with a transcript · latest Nov 19, 2026
- Decks
- 27 decks · latest Nov 19, 2026
Where Halma plc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| LSE:HLMA · Home listing | LSE | United Kingdom | GBX |
| gettex:H11 | gettex | Germany | EUR |
| OTC:HALMY | OTC | United States | USD |
| OTC:HLMAF · This page | OTC | United States | USD |
| Tradegate:H11 | Tradegate | Germany | EUR |
| LS Exchange:865047 | LS Exchange | Germany | EUR |
| Lang & Schwarz:865047 | Lang & Schwarz | Germany | EUR |
| Frankfurt:H11 | Frankfurt | Germany | EUR |
| Aquis:HLMAL | Aquis | United Kingdom | GBX |
| Turquoise:HLMAL | Turquoise | United Kingdom | GBX |
| Stuttgart:H11 | Stuttgart | Germany | EUR |
| BIVA:HLMAN | BIVA | Mexico | MXN |
| Munich:H11 | Munich | Germany | EUR |
| BMV:HLMAN | BMV | Mexico | MXN |
| BX Swiss:H11 | BX Swiss | Switzerland | CHF |
| Dusseldorf:H11 | Dusseldorf | Germany | EUR |
| Frankfurt:H110 | Frankfurt | Germany | EUR |
| Hanover:H11 | Hanover | Germany | EUR |
Valuation
Statements: Year to Mar 31, 2026 · balance Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- £12.24B GBP
- P/E
- 33.0×
- EV/sales
- 4.7×
- EV/EBITDA
- 18.6×
- Price/book
- 5.4×
- Gross margin
- 49.8%
- Operating margin
- 20.4%
- Net margin
- 14.4%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Forecasts
Analysts' consensus from EODHD, read Nov 21, 2026. Not 6ix's view and not investment advice.
- Price target
- 4373.89 GBX · Analysts' mean
- EPS, year to Mar 2027
- 1.36 · 16 analysts
- Revenue, year to Mar 2027
- 2.98B · 14 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Bill Stoval | Healthcare Sector Chief Executive |
| Carole Cran | Chief Financial |
| Mark Jenkins | Company Secretary |
| Charles King | Co-Head of Investor Relations |
| Melanie Horton | Co-Head of Investor Relations |
Board
| Director | Role |
|---|---|
| Louise Makin | Chair |
| Barbara Thoralfsson | Non-Executive Director |
| Dharmash Mistry | Non-Executive Director |
| Giles Kerr | Chair of Remuneration Committee |
| Hudson La Force | Non-Executive Director |
| Liam Condon | Non-Executive Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Halma (LSE:HLMA) Q2 2027 Earnings Call | Thu, Nov 19, 2026 · 3:30 AM ET | Replay |
| Halma (LSE:HLMA) Q4 2026 Earnings Call | Thu, Jun 11, 2026 · 3:30 AM ET | Replay |
| Halma (LSE:HLMA) Q2 2026 Earnings Call | Thu, Nov 20, 2025 · 3:30 AM ET | Replay |
| Halma (LSE:HLMA) Q4 2025 Earnings Call | Thu, Jun 12, 2025 · 3:30 AM ET | Replay |
| Halma (LSE:HLMA) Q2 2025 Earnings Call | Thu, Nov 21, 2024 · 3:30 AM ET | Replay |
| Halma (LSE:HLMA) Q4 2024 Earnings Call | Sat, Jul 13, 2024 · 3:30 AM ET | Replay |
| Halma (LSE:HLMA) Q2 2024 Earnings Call | Thu, Nov 16, 2023 · 3:30 AM ET | Replay |
| Halma (LSE:HLMA) Q4 2023 Earnings Call | Thu, Jun 15, 2023 · 3:30 AM ET | Replay |
| Halma (LSE:HLMA) — Investor Update | Mon, Jan 31, 2022 · 9:30 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q2 2027 | Nov 19, 2026 · After close | −4.4% |
| Q2 2026 | Nov 20, 2025 · After close | −2.2% |
| Q4 2025 | Jun 12, 2025 · Before open | +3.3% |
| Q2 2025 | Nov 21, 2024 | +7.7% |
| Q4 2024 | Jun 13, 2024 | +12.6% |
| Q2 2024 | Nov 16, 2023 | +4.5% |
| Q4 2023 | Jun 15, 2023 · Before open | −3.4% |
| Q2 2023 | Nov 17, 2022 · Before open | −4.3% |
| Q4 2022 | Jun 16, 2022 · Before open | −5.7% |
| Q2 2022 | Nov 18, 2021 | +1.3% |
All 11 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2021 | Jun 10, 2021 | +2.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| H1 2026/27 Earnings Presentation | Earnings | 40 slides | Nov 19, 2026 |
| FY2026 Earnings Presentation | Earnings | 44 slides | Jun 11, 2026 |
| Q4 2026 Earnings Presentation | Earnings | 24 slides | Jun 11, 2026 |
| H1 2026 Earnings Presentation | Earnings | 39 slides | Nov 20, 2025 |
| FY2025 Earnings Presentation | Earnings | 43 slides | Jun 12, 2025 |
| H1 2025 Earnings Presentation | Earnings | 41 slides | Nov 21, 2024 |
| FY2024 Earnings Presentation | Earnings | 47 slides | Jul 13, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 40 slides | Nov 16, 2023 |
| FY2023 Earnings Presentation | Earnings | 44 slides | Jun 15, 2023 |
| H1 2022/23 Earnings Presentation | Earnings | 37 slides | Nov 17, 2022 |
All 27 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY2021/22 Earnings Presentation | Earnings | 41 slides | Jun 16, 2022 |
| Investor Day (April 2022) | Investor day | 33 slides | Apr 7, 2022 |
| H1 2021/22 Earnings Presentation | Earnings | 35 slides | Nov 18, 2021 |
| FY2021 Earnings Presentation | Earnings | 41 slides | Jun 10, 2021 |
| Investor Day (October 2019) | Investor day | 31 slides | Oct 1, 2019 |
| FY2018/19 Earnings Presentation | Earnings | 38 slides | Jun 11, 2019 |
| H1 2016/17 Earnings Presentation | Earnings | 38 slides | November 2016 |
| Investor Day (September 2016) | Investor day | 49 slides | Sep 29, 2016 |
| FY2015/16 Earnings Presentation | Earnings | 47 slides | June 2016 |
| H1 2015/16 Earnings Presentation | Earnings | 40 slides | November 2015 |
| Investor Day (September 2015) | Investor day | 22 slides | Sep 17, 2015 |
| FY2014/15 Earnings Presentation | Earnings | 45 slides | June 2015 |
| FY2013/14 Earnings Presentation | Earnings | 44 slides | June 2014 |
| H1 2013/14 Earnings Presentation | Earnings | 38 slides | Nov 19, 2013 |
| FY2012/13 Earnings Presentation | Earnings | 48 slides | June 2013 |
| Investor Day (February 2013) | Investor day | 38 slides | Feb 14, 2013 |
| H1 2012/13 Earnings Presentation | Earnings | 38 slides | November 2012 |
Financials
Annual, in GBP
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.58B | 2.25B | 2.03B | 1.85B | 1.53B | 1.32B | 1.34B | 1.21B | 1.08B | 961.7M |
| Cost of revenue | 1.30B | 1.11B | 1.02B | 974.9M | 801.0M | 704.6M | 707.1M | 609.2M | 506.1M | 450.5M |
| Gross profit | 1.29B | 1.13B | 1.01B | 877.9M | 724.3M | 613.6M | 631.3M | 601.7M | 570.1M | 511.1M |
| Research and development | 93.0M | 80.8M | 123.7M | 71.2M | 58.6M | 39.5M | 42.6M | 68.7M | 62.5M | 46.7M |
| Selling, general and administrative | 515.4M | 485.8M | 415.4M | 404.4M | 316.7M | 267.9M | 270.1M | 231.8M | 218.3M | 187.5M |
| Operating income | 525.8M | 409.5M | 367.7M | 308.4M | 278.9M | 252.3M | 245.6M | 219.0M | 187.2M | 168.4M |
| Depreciation and amortization | 131.0M | 120.3M | 105.6M | 101.6M | 88.9M | 91.2M | 84.7M | 66.2M | 62.3M | 57.6M |
| EBITDA | 656.8M | 529.8M | 473.3M | 410.0M | 367.8M | 343.5M | 330.3M | 285.2M | 249.5M | 226.1M |
| Interest expense | 36.0M | 33.3M | 30.7M | 18.7M | 9.00M | 10.8M | 11.7M | 9.00M | 8.15M | 8.14M |
| Income before tax | 490.7M | 384.3M | 340.3M | 291.5M | 304.4M | 252.9M | 224.2M | 206.7M | 171.9M | 157.7M |
| Income tax | 118.4M | 87.9M | 71.5M | 57.2M | 60.2M | 49.6M | 39.7M | 36.9M | 17.7M | 28.0M |
| Net income | 372.3M | 296.4M | 268.8M | 234.5M | 244.4M | 203.4M | 184.4M | 169.8M | 154.2M | 129.7M |
| Earnings per share, basic | 0.99 | 0.78 | 0.71 | 0.62 | 0.65 | 0.54 | 0.49 | 0.45 | 0.41 | 0.34 |
| Earnings per share, diluted | 0.98 | 0.78 | 0.71 | 0.62 | 0.64 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 143.4M | 312.7M | 142.4M | 168.5M | 156.7M | 134.1M | 106.3M | 81.2M | 70.7M | 66.8M |
| Short-term investments | 1 | 705.0K | 598.0K | |||||||
| Receivables | 601.0M | 485.9M | 460.9M | 410.7M | 325.1M | 241.9M | 257.3M | 230.8M | 209.0M | 187.0M |
| Inventory | 322.2M | 300.3M | 304.8M | 312.4M | 228.8M | 167.8M | 170.6M | 144.3M | 128.0M | 118.8M |
| Current assets | 1.12B | 1.12B | 911.7M | 895.6M | 712.7M | 574.1M | 575.2M | 486.2M | 435.4M | 398.6M |
| Property, plant and equipment | 283.2M | 236.8M | 222.9M | 194.0M | 180.8M | 184.3M | 112.4M | 103.7M | ||
| Goodwill | 1.51B | 1.26B | 1.21B | 1.12B | 908.7M | 808.5M | 838.4M | 694.0M | 632.1M | 603.6M |
| Total assets | 3.71B | 3.26B | 3.00B | 2.79B | 2.20B | 1.88B | 1.94B | 1.54B | 1.45B | 1.40B |
| Accounts payable | 396.9M | 343.3M | 296.5M | 280.7M | 242.7M | 84.8M | 89.5M | 82.1M | 77.5M | 73.4M |
| Current liabilities | 522.4M | 457.8M | 372.1M | 341.2M | 363.9M | 248.0M | 313.2M | 213.1M | 171.9M | 159.3M |
| Long-term debt | 756.7M | 703.8M | 711.9M | 677.3M | 287.6M | 322.3M | 345.0M | 253.7M | 289.9M | 261.9M |
| Total debt | 805.6M | 739.4M | 712.2M | 678.3M | 360.1M | 390.3M | 481.6M | 262.9M | 291.1M | 263.3M |
| Total liabilities | 1.54B | 1.36B | 1.26B | 1.19B | 793.9M | 709.6M | 800.2M | 561.7M | 618.4M | 624.3M |
| Shareholders' equity | 2.17B | 1.90B | 1.74B | 1.60B | 1.40B | 1.17B | 1.14B | 981.4M | 828.4M | 778.6M |
| Shares outstanding | 379.2M | 379.2M | 378.7M | 379.1M | 379.4M | 379.2M | 379.1M | 379.2M | 379.0M | 378.7M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 480.6M | 492.4M | 385.0M | 258.0M | 237.4M | 277.6M | 255.5M | 219.0M | 173.3M | 172.5M |
| Capital spending | -54.9M | -43.8M | -32.8M | -29.0M | -25.2M | -42.2M | -48.8M | -26.4M | -20.2M | -21.9M |
| Free cash flow | 425.7M | 448.6M | 352.2M | 229.0M | 212.2M | 235.4M | 206.7M | 192.6M | 153.1M | 150.6M |
| Cash from investing | -498.9M | -163.9M | -286.3M | -368.9M | -134.7M | -64.2M | -276.4M | -104.0M | -141.4M | -43.6M |
| Cash from financing | -153.7M | -155.1M | -119.7M | 121.0M | -81.9M | -183.5M | 53.7M | -113.6M | -25.8M | -116.6M |
| Dividends paid | -89.7M | -83.8M | -78.2M | -73.3M | -68.7M | -63.7M | -61.2M | -57.2M | -53.4M | -49.8M |
| Share buybacks | -33.5M | -7.90M | -21.1M | -22.3M | -19.3M | -16.2M | -16.7M | -3.80M | -2.60M | -2.37M |
| Change in cash | -172.0M | 173.4M | -21.0M | 10.1M | 20.8M | 25.7M | 33.3M | 2.40M | 4.06M | 16.1M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Half Year Results | Nov 19, 2026 | Results | London Stock Exchange |
Cap table
Built by 6ix from Halma plc’s releases
- Common shares
- 377,678,275
- Fully diluted
- 377,678,275
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 377,678,275 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 377,678,275 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Louise Makin Other companies: Avantor, Inc. (Director · Since at least Nov 4, 2024) | Chair · Since at least Jul 24, 2025 |
| Sharmila Nebhrajani Other companies: Severn Trent PLC (Chair · Since at least Jul 10, 2025) | Until May 28, 2026 · Past |
| Barbara Thoralfsson | Non-Executive Director · Since at least Jul 24, 2025 |
| Bill Stoval | Healthcare Sector Chief Executive · Since May 28, 2026 · Appointed, no departure found |
| Bill Stoval | Healthcare Sector Chief Executive · Since at least May 28, 2026 |
| Carole Cran | Chief Financial · Since at least Jun 11, 2026 |
| Charles King | Co-Head of Investor Relations · Since at least Jun 12, 2026 |
| Constance Baroudel | Environmental & Analysis Sector Chief Executive · Until May 28, 2026 · Past |
| Dharmash Mistry | Non-Executive Director · Since at least Jul 24, 2025 |
| Giles Kerr | Chair of Remuneration Committee · Since at least Jun 12, 2026 |
All 14 people
| Person | Seat |
|---|---|
| Hudson La Force | Non-Executive Director · Since at least Jan 13, 2026 |
| Liam Condon | Non-Executive Director · Since at least Jul 24, 2025 |
| Mark Jenkins | Company Secretary · Since at least Oct 1, 2026 |
| Melanie Horton | Co-Head of Investor Relations · Since at least May 28, 2026 |
Log in to ask 6ix AI your own questions about Halma plc.